Instrument Inactif

Autres langues CB Scientific, Inc. Other OTC

Actions

CBSC

US12506E1038

Autres langues

15/01	Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
26/09/25	Cardiac Biotech Solutions Unlocks Canadian Market with Health Canada Approval for its Innovative Heart Monitor
25/09/25	Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT
25/09/25	Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT
11/09/25	Cardiac Biotech Solutions, Inc. Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical
11/09/25	CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical
04/09/25	Cardiac Biotech Solutions, Inc. Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina
04/09/25	Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina
08/05/25	CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.
03/10/24	CB Scientific, Inc. Announces Chief Financial Officer Changes
12/01/24	CB Scientific, Inc. 2023 Year in Review
06/09/22	CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor
23/08/22	CB Scientific : Entry into Material Definitive Agreement
12/08/22	CB Scientific : For the Period Ending June 30, 2022
12/08/22	CB Scientific : As of August 12, 2022
28/06/22	CB Scientific : For the Annual Report for the Fiscal Year Ended March 31, 2022
03/05/22	CB Scientific, Inc. Appoints James Ott as Chief Technology Officer
28/10/21	CB Scientific, Inc. Appoints Paul Danner as Chairman
02/03/21	CB Scientific, Inc. Announces Appointment of Jeslie Chui as New Director for Asia Pacific
23/02/21	CB Scientific, Inc. Discusses the Potential of Their Proprietary Cardiac Event Monitor, my-Cam, with The Stock Day Podcast
23/02/21	CB Scientific, Inc. has signed a definitive agreement to acquire Cardiolink Corporation.
28/12/20	CB Scientific. Inc. Announces Addition of Dozens of New Device Clinical Trials of my-Cam Device and New Hospital Monitoring Contracts Through Mango Wellness Co., Ltd. and My Cardia Thailand Co., Ltd
28/12/20	CB Scientific, Inc. (CBSC), Distributor Mango Wellness and My Cardia Thailand Well Positioned for Growth in 2021
12/11/20	CB Scientific : CBSC) Announces Definitive Agreement to Acquire Commercial Ambulatory ECG Device Manufacturer Datrix, LLC
12/11/20	CB Scientific, Inc. (CBSC) Announces Definitive Agreement to Acquire Commercial Ambulatory ECG Device Manufacturer Datrix, LLC